Tenax Therapeutics Stock Analysis

Tenax Stock Analysis Notes

The company has price-to-book ratio of 0.91. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Tenax Therapeutics recorded a loss per share of 31.04. The entity last dividend was issued on the 26th of February 2018. The firm had 1:80 split on the 3rd of January 2024. Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina. Tenax Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 8 people. To find out more about Tenax Therapeutics contact Christopher Giordano at 919 855 2100 or learn more at https://www.tenaxthera.com.

Tenax Therapeutics Investment Alerts

Tenax Therapeutics Upcoming and Recent Events

Tenax Largest EPS Surprises

View All Earnings Estimates

Tenax Stock Institutional Investors

Note, although Tenax Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Tenax Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.85 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Tenax Therapeutics's market, we take the total number of its shares issued and multiply it by Tenax Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Tenax Profitablity

Management Efficiency

Tenax Therapeutics has return on total asset (ROA) of (0.6821) % which means that it has lost $0.6821 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.6079) %, meaning that it created substantial loss on money invested by shareholders. Tenax Therapeutics' management efficiency ratios could be used to measure how well Tenax Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.69 in 2024. Return On Capital Employed is likely to rise to -0.97 in 2024. At this time, Tenax Therapeutics' Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 2 M in 2024, whereas Non Current Assets Total are likely to drop 1,061 in 2024.

Technical Drivers

As of the 24th of April, Tenax Therapeutics has the Variance of 118.98, risk adjusted performance of (0.03), and Coefficient Of Variation of (1,544). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Tenax Therapeutics, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate thirteen technical drivers for Tenax Therapeutics, which can be compared to its competition. Please validate Tenax Therapeutics market risk adjusted performance and treynor ratio to decide if Tenax Therapeutics is priced more or less accurately, providing market reflects its prevalent price of 3.5 per share. Given that Tenax Therapeutics has information ratio of (0.07), we advise you to double-check Tenax Therapeutics's current market performance to make sure the company can sustain itself at a future point.

Tenax Therapeutics Price Movement Analysis

Tenax Therapeutics Insider Trading Activities

Tenax Therapeutics Predictive Daily Indicators

Tenax Therapeutics Corporate Filings

Tenax Therapeutics Forecast Models

Tenax Therapeutics' time-series forecasting models are one of many Tenax Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Tenax Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Tenax Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Tenax shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Tenax Therapeutics. By using and applying Tenax Stock analysis, traders can create a robust methodology for identifying Tenax entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Tenax analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Tenax analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Tenax Therapeutics stock analysis indicators help investors evaluate how Tenax Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Tenax Therapeutics shares will generate the highest return on investment. By understating and applying Tenax Therapeutics stock analysis, traders can identify Tenax Therapeutics position entry and exit signals to maximize returns.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenax Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Tenax Stock please use our How to Invest in Tenax Therapeutics guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.

Is Tenax Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tenax Therapeutics. If investors know Tenax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tenax Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Tenax Therapeutics is measured differently than its book value, which is the value of Tenax that is recorded on the company's balance sheet. Investors also form their own opinion of Tenax Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Tenax Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tenax Therapeutics' market value can be influenced by many factors that don't directly affect Tenax Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Tenax Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tenax Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tenax Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.